Remedium Bio announces the publication of preclinical data demonstrating the performance of its adjustable dose gene therapy platform – Prometheus™
Posted:
Prometheus™ was specifically designed as a subcutaneously injected gene delivery system, utilizing the same route of administration as most current therapeutic biologics. Remedium is applying the Prometheus™ platform technology to the development of its lead candidate RMD1202, a single injection disease-modifying treatment for type 2 diabetes and obesity.
Where nature becomes power. Where skin becomes transformation.
GIANT Health Event 2026 is pleased to welcome ENOWA Natural Skincare as an exhibitor, bringing a fresh approach to skincare innovation rooted in the power of nature.
ENOWA combines natural ingredients, thoughtful…
Healthcare robotics is rapidly transforming the way hospitals and care providers deliver services, improve operational efficiency, and enhance patient experiences. At GIANT Health Event 2026, visitors will have the opportunity to see these innovations in action as Robot Center joins…
Attendees
Sponsors and Exhibitors
Contact us